Floatz logo

Therapeutic Asset Ratings

18,134 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Jnj-54135419
Bipolar Depression
Dr. Inge WinterP3BB (65)
Ketorolac
Substance-Related Disorder
Wake Forest University Health SciencesP3BB (65)
Lidocaine
Renal Cell Carcinoma
University Hospital of SplitP3BB (65)
Lomustine
Gliosarcoma
NRG OncologyP3BB (65)
Megestrol Acetate
Cancer
Sixth Affiliated Hospital, Sun Yat-sen UniversityP3BB (65)
Mesna
Lymphoma
Center for International Blood and Marrow Transplant ResearchP3BB (65)
Metformin
Non-Small Cell Lung Carcinoma
Instituto Nacional de Cancerologia de MexicoP3BB (65)
Methotrexate
Childhood Acute Myeloid Leukemia
Children's Oncology GroupP3BB (65)
Methotrexate
Non-Hodgkin Lymphoma
Sun Yat-sen UniversityP3BB (65)
Midazolam
Depressive Disorder
Federal University of São PauloP3BB (65)
Mifepristone
Breast Cancer
Memorial Sloan Kettering Cancer CenterP3BB (65)
Mitapivat
Sickle Cell Disease
Agios Pharmaceuticals, Inc.P3BB (65)
Mobocertinib
Non-Small Cell Lung Carcinoma
TakedaP3BB (65)
Muamycin
Non-Small Cell Lung Carcinoma
City of Hope Medical CenterP3BB (65)
Muamycin
Appendix Adenocarcinoma
City of Hope Medical CenterP3BB (65)
Muamycin
Peritoneum Cancer
City of Hope Medical CenterP3BB (65)
Nelarabine
Lymphoblastic Lymphoma
Emory UniversityP3BB (65)
Nelarabine
T-Cell Acute Lymphoblastic Leukemia
Children's Oncology GroupP3BB (65)
Oxybutynin
Overactive Bladder
University of California, DavisP3BB (65)
Prednisolone
Metastatic Neoplasm
Eli Lilly and CompanyP3BB (65)
Prednisone
Cancer
ExelixisP3BB (65)
Prednisone
Mixed Phenotype Acute Leukemia
St. Jude Children's Research HospitalP3BB (65)
Procarbazine
Classic Hodgkin Lymphoma
Merck Sharp & Dohme LLCP3BB (65)
Pyrotinib
Non-Small Cell Lung Carcinoma
RemeGen Co., Ltd.P3BB (65)
Raloxifene
Breast Cancer
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB ChairP3BB (65)
Showing 3926 to 3950 of 18,134 assets
PreviousPage 158 of 726Next